NCT03657628View on ClinicalTrials.gov

Physical Activity, Proliferation and Immune Markers in Benign Breast Tissue

NAActive, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 17, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

August 31, 2025

Conditions
Breast Cancer
Interventions
OTHER

Exercise Intervention

Strength training and moderate-intensity, aerobic exercise

Trial Locations (1)

02215

Dana Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER

NCT03657628 - Physical Activity, Proliferation and Immune Markers in Benign Breast Tissue | Biotech Hunter | Biotech Hunter